openPR Logo
Press release

Clinical Oncology Next Generation Sequencing Market is Thriving Worldwide By Size, Revenue, Emerging Trends and Top Growing Companies 2027

09-18-2020 03:00 PM CET | Health & Medicine

Press release from: Transparency Market Research

Clinical Oncology Next Generation Sequencing: Introduction
Next generation sequencing for tumor and germline DNA is required for oncology screening for therapeutic application. Rise in burden of cancer increases the need for early detection of the condition to carry out the generate target therapy.
Companies are investing to develop technologically advanced devices/solutions for precision detection. In 2012, Oxford Nanopore had launched the GridION sequencing platform, which can sequence a human genome in 15 minutes. In 2012, Ion Torrent had stated that their Ion Proton benchtop sequencer device could sequence an entire human genome in a day for less than US$ 1,000. In November 2019, Thermo Fisher Scientific launched its fully integrated next-generation sequencing (NGS) platform, Ion Torrent Genexus System, featuring an automated specimen-to-report workflow that delivers results economically in a single day.
Get Brochure of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=74625

Key Drivers and Restraints of Global Clinical Oncology Next Generation Sequencing Market
Rise in burden of cancer and its early diagnosis for treatment is fueling market growth. According to the 2018 GLOBOCAN database, the global cancer burden was predicted to rise to 18.1 million new cases, 9.6 million cancer deaths, and 43.8 million people living with cancer in 2018. Majority of cancer incidences occur in Asia and about one-quarter in Europe.
Increase in investments for oncology research is also driving the global clinical oncology next generation sequencing market. In 2019, Cancer Research UK invested US$ 262.90 Mn to focus on companies developing innovative oncology treatments. As per CB Insights, a research firm, equity investments in cancer-therapeutics startups grew from US$ 2 Bn in 2013 to US$ 4.5 Bn in 2017.
Non-value-based NGS reimbursement policy hampers market growth due to relatively high total costs of delivering NGS test results compared to other technology platforms, and limited coverage by payers
Targeted Sequencing & Resequencing Technology for Skin Treatment to Witness High Demand
Based on technology, the global clinical oncology next generation sequencing market can be segmented into whole genome sequencing, whole exome sequencing, and targeted sequencing & resequencing
Targeted sequencing & resequencing segment dominates the clinical oncology next generation sequencing market, in terms of revenue generation. This technique is useful in analyzing specific mutations. Multiple genes can also be assessed across several samples in parallel. Due to its cost-effective findings, and accurate and easy-to-interpret results, targeted sequencing & resequencing holds a leading share of the global market. AmpliSeq offered by Illumina, Inc. is a comprehensive targeted resequencing solution, which can detect mutation in a few to hundreds of genes samples.
Whole genome sequencing segment is expected to grow significantly during the forecast period. Due to decrease in sequencing cost and expansion of computer resources, the whole genome sequencing technology will become common and sophisticated, as it provides sufficient information to understand the biology underlying the cancer genome and function of unexplored non?coding regions.
Request For Covid19 Impact Analysis – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=74625

Companion Diagnostic Segment to Witness Rapid Growth
Based on application, the global clinical oncology next generation sequencing market can be segregated into screening, companion diagnostics, and other diagnostics. Screening segment can be further divided into sporadic cancer and inherited cancer.
Demand for whole exome and genome sequencing tests is rapidly increasing for the screening of cancer to offer targeted diagnostic and treatment market for oncology. The next generation sequencing technology in the field of clinical oncology is applied in genetic diagnosis, cancer classification to prepare predictive biomarkers, and personalized medicine.
Companion diagnostic segment is expected to grow at a rapid rate due to numerous benefits offered by the technology in the field of oncology. In 2018, The Centers for Medicare & Medicaid Services (CMS) announced that it will pay for next generation sequencing (NGS)–based companion diagnostics for its beneficiaries with advanced cancer.
Buy Now Report : https://www.transparencymarketresearch.com/checkout.php?rep_id=74625<ype=S

North America to Dominate Global Market for Clinical Oncology Next Generation Sequencing
In terms of region, the global clinical oncology next generation sequencing market can be divided into: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
North America holds the major share of the global market due to rise in government initiatives investments in researches, and presence of high-quality health care infrastructure. Furthermore, increase in incidences of cancer and high demand for personalized medicine are likely to boost the market in the region.
This market in Asia Pacific is projected to expand at a rapid CAGR during the forecast period, owing to the clinical oncology next generation sequencing market growth in emerging countries and continuous development in health care and pharmaceutical industries in the region. Countries with highest cancer rate includes Australia and New Zealand.
Read our Case study at : https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up

Key Manufacturers Operating in Global Market
The global clinical oncology next generation sequencing market was highly fragmented in 2018. Key manufacturers operating in the global market are:

Illumina, Inc.
F. Hoffmann-La Roche Ltd
Oxford Nanopore Technologies
Agilent Technologies
Thermo Fischer Scientific Inc.
PerkinElmer, Inc.
BD
Qiagen N.V.
Pacific Biosciences of California, Inc.
Takara Bio, Inc.
Creative Biolabs
Mogene LC
Clinical Oncology Next Generation Sequencing Market: Research Scope
Clinical Oncology Next Generation Sequencing Market, by Product & Services

Products
Sequencing platform
Kits & Reagents
Services
Clinical Oncology Next Generation Sequencing Market, by Technology

Whole Genome Sequencing
Whole Exome Sequencing
Targeted Sequencing & Resequencing
Clinical Oncology Next Generation Sequencing Market, by Application

Screening
Sporadic Cancer
Inherited cancer
Companion Diagnostics
Other Diagnostics
Clinical Oncology Next Generation Sequencing Market, by End-user

Hospital Laboratories
Clinical Research Organization
Pharma & Biotech Companies
Diagnostic Laboratories
Others
Clinical Oncology Next Generation Sequencing Market, by Region

North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
More Trending Reports by Transparency Market Research – 1. http://www.prnewswire.com/news-releases/despite-several-factors-supporting-osteoporosis-drugs-market-patent-expiration-of-blockbuster-drugs-to-hamper-markets-progress-tmr-301019711.html

2. https://www.biospace.com/article/3d-applications-in-health-care-market-applications-of-3d-printing-technology-to-disrupt-paradigms-in-healthcare-services-and-medicine-tmr/

Contact

Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Clinical Oncology Next Generation Sequencing Market is Thriving Worldwide By Size, Revenue, Emerging Trends and Top Growing Companies 2027 here

News-ID: 2137220 • Views:

More Releases from Transparency Market Research

Tree Nut Allergy Market Size is Anticipated to Reach USD 433.2 million by 2031 | Transparency Market Research
Tree Nut Allergy Market Size is Anticipated to Reach USD 433.2 million by 2031 | …
The Tree Nut Allergy Market is driven by the increasing prevalence of food allergies, growing awareness of allergen labeling, and advancements in allergy management strategies. Key stakeholders in the market include allergists, immunologists, primary care physicians, food manufacturers, regulatory agencies, and patient advocacy groups. Treatment approaches focus on allergen avoidance, symptom management, emergency preparedness, and desensitization therapies tailored to individual patient needs and preferences. Tree Nut Allergy market is estimated to
Dyspareunia Treatment Market Size is Anticipated to Reach USD 1.02 billion by 20 …
The Dyspareunia Treatment Market is driven by the increasing awareness of sexual health issues, growing patient demand for effective treatment options, and advancements in medical research and technology. Key stakeholders in the market include gynecologists, urologists, sexual health clinics, mental health professionals, and pharmaceutical companies. Treatment approaches focus on addressing underlying causes of dyspareunia, such as hormonal imbalances, pelvic floor dysfunction, vaginal dryness, psychological distress, or anatomical abnormalities, through multimodal
Nanorobotics in Medicine Market Size is Anticipated to Boom at a CAGR of 10.3% by 2031 |Transparency Market Research
Nanorobotics in Medicine Market Size is Anticipated to Boom at a CAGR of 10.3% b …
The Nanorobotics in Medicine Market is driven by advancements in nanotechnology, robotics, materials science, and biomedical engineering. Key stakeholders in the market include academic research institutions, nanotechnology companies, medical device manufacturers, pharmaceutical firms, and healthcare providers. Nanorobots offer unique capabilities such as targeted drug delivery, tissue engineering, imaging enhancement, and minimally invasive surgery, making them promising tools for addressing unmet medical needs and improving patient outcomes. Nanorobotics in Medicine market is
Radiopharmaceutical Theranostics Market Size is Expected to expand at a CAGR of 15.1% by 2031 |Transparency Market Research
Radiopharmaceutical Theranostics Market Size is Expected to expand at a CAGR of …
The Radiopharmaceutical Theranostics Market involves the use of radiopharmaceuticals for both diagnostic imaging (diagnostics) and targeted therapy (therapeutics) in the management of various diseases, including cancer, neuroendocrine tumors, and cardiovascular conditions. Theranostics refers to the integration of diagnostic and therapeutic modalities, allowing for personalized medicine approaches tailored to individual patient characteristics. Radiopharmaceuticals, which emit radiation for imaging or therapeutic purposes, play a crucial role in diagnosing, staging, and treating diseases

All 5 Releases


More Releases for Sequencing

Next Generation Sequencing Market Growth of Technological Advancements in Sequen …
Research Report on Next Generation Sequencing Market providing Global Industry Scenario for 5 years (2019 to 2026) is now available under the Life Sciences Section of Search4Research.com Get Research Sample PDF at https://www.search4research.com/request-sample/113582/ Global Next Generation Sequencing Market Trends, Competitive Analysis and Forecast Report 2018-2026 is an exhaustive study on the present market scenario of the global Next Generation Sequencing industry with a special focus on the United States, Europe,
Metagenomic Sequencing Market Technology Outlook 2027 - 16s Rrna Sequencing, Sho …
Worldwide Metagenomic Sequencing Market Analysis to 2027 is a specialized and in-depth study of the Metagenomic Sequencing Industry with a focus on the global market trend. The report aims to provide an overview of global Metagenomic Sequencing Market with detailed market segmentation by product/application and geography. The global Metagenomic Sequencing Market is expected to witness high growth during the forecast period. Metagenomics, is a field where genomic analysis of microbial DNA
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may
Precision Medicine Market Report 2018: Segmentation by Technology (Genomics, Tra …
Global Precision Medicine market research report provides company profile for Abbott Laboratories, Almac Group, Ltd, Asuragen, Inc., Cepheid Inc, Cetics Healthcare Technologies GmbH, Ge Healthcare, Glaxosmithkline Plc, Intomics A/S., Biocrates Life Sciences Ag, Pfizer Inc. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth
Next Generation Sequencing (NGS) Market, By Technology (Whole Exon Sequencing (W …
The next generation sequencing market is estimated to represent a global market of USD 5,618 million by 2017 with growth rate of 9.1%. Next-generation sequencing (NGS) involves an advanced level of genetic sequencing which is a level above the conventional methods such as capillary electrophoresis-based Sanger sequencing. NGS procedure is a multi-step process where a number of smaller laboratory processes combine to form the whole next-generation sequencing process. This includes
Next Generation Sequencing Market Global Analysis and Forecasts by Service (Geno …
ReportsWeb.com has announced the addition of the “Next Generation Sequencing Market to 2025”, the report classifies the global Next Generation Sequencing Market in a precise manner to offer unearth valuable, accurate and reliable data insights that help organizations to meet their business objectives and enable growth. The next generation market is estimated to account for US$ 26,501.2 Mn by the end of 2025, escalating at a CAGR of 21.1% during the